Staff Scientist - Pediatric Immunotherapy and CAR T Cell Engineering jobs in United States
cer-icon
Apply on Employer Site
company-logo

City of Hope · 4 weeks ago

Staff Scientist - Pediatric Immunotherapy and CAR T Cell Engineering

City of Hope is a leading research institute focused on pediatric immunotherapy. They are seeking a Staff Scientist to design and lead projects aimed at enhancing CAR T cell function, coordinating lab operations, and mentoring lab members.

AssociationEducationHealth Care
check
Comp. & Benefits

Responsibilities

Design and lead projects focused on understanding and augmenting CAR T cell function in specific microenvironmental contexts, using canonical immune signaling and activation as a conceptual framework
Coordinate lab tasks and operations among multiple lab members, including mentoring, training, and oversight; providing conceptual, technical, and experimental assistance; contributing to manuscripts and grant applications; and assembling reports and presentations
Keep detailed and accurate logs of experimental design and primary data, analysis, and synthesis
Prepare data presentations and manuscripts for publication
Organize and maintain project workflow, both internally and in collaborations with other labs

Qualification

ImmunologyCellMolecular biologyFlow cytometryProtein biochemistryMouse workProgramming RProgramming PythonData presentationExperimental designMentoring

Required

The Staff Scientist must possess, at a minimum, a Ph.D. or other doctoral level degree, or equivalent professional experience
Core competencies include cell and molecular biology, flow cytometry, protein biochemistry, and mouse work
Extensive prior experience in immunology or a closely related field

Preferred

Ph.D. or equivalent degree and 5 or more years of postdoctoral experience
Programming experience (R, Python)

Benefits

Comprehensive Benefits

Company

City of Hope

company-logo
City of Hope is a cancer research and treatment non-profit organization specializing in diabetes and other life-threatening illnesses.

Funding

Current Stage
Late Stage
Total Funding
$10.3M
Key Investors
California Institute for Regenerative Medicine
2024-05-20Grant· $5.4M
2022-02-22Grant· $4.9M

Leadership Team

leader-logo
Samuel Lau
Vice President Marketing & Digital Communications
linkedin
leader-logo
Alan H. Bryce
Chief Clinical Officer
linkedin
Company data provided by crunchbase